Found: 12
Select item for more details and to access through your institution.
Significance of Serum Matrix Metalloproteinases and Their Inhibitors on the Antifibrogenetic Effect of Interferon-Alfa in Chronic Hepatitis C Patients.
- Published in:
- Intervirology, 2001, v. 44, n. 4, p. 227, doi. 10.1159/000050052
- By:
- Publication type:
- Article
Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 531, doi. 10.1159/000480143
- By:
- Publication type:
- Article
Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated- Interferon/Ribavirin Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030513
- By:
- Publication type:
- Article
Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.
- Published in:
- Oncogene, 2003, v. 22, n. 30, p. 4656, doi. 10.1038/sj.onc.1206588
- By:
- Publication type:
- Article
IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat.
- Published in:
- Carcinogenesis, 2004, v. 25, n. 3, p. 389
- By:
- Publication type:
- Article
Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?
- Published in:
- Biomedical Reports, 2017, v. 7, n. 3, p. 257, doi. 10.3892/br.2017.944
- By:
- Publication type:
- Article
Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-a: Histological evaluation by a modified histological activity index scoring system.
- Published in:
- Journal of Gastroenterology & Hepatology, 1998, v. 13, n. 1, p. 68
- By:
- Publication type:
- Article
Primary Presacral Neuroendocrine Tumor Presenting as Multiple Liver Metastasis: A Case Report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Mutational diversity of NS5A and NS3 during triple therapy(telaprevir, pegylated-interferon-α 2b and ribavirin)for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group.
- Published in:
- International Journal of Molecular Medicine, 2014, v. 33, n. 6, p. 1652, doi. 10.3892/ijmm.2014.1706
- By:
- Publication type:
- Article
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.
- Published in:
- JGH Open, 2023, v. 7, n. 7, p. 476, doi. 10.1002/jgh3.12932
- By:
- Publication type:
- Article
Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.
- Published in:
- JGH Open, 2022, v. 6, n. 6, p. 427, doi. 10.1002/jgh3.12772
- By:
- Publication type:
- Article
Apoptotic pathway related to oval cell proliferation.
- Published in:
- Journal of Gastroenterology & Hepatology, 2004, v. 19, n. 8, p. 866, doi. 10.1111/j.1440-1746.2004.03431.x
- By:
- Publication type:
- Article